:::: MENU ::::

Manning Advisors LLC

MANNING ADVISORS LLC
Assisting our clients to recognize the value of equity

News and Advisories

  • Jun 26 / 2012
  • Comments Off on Teleflex acquires Semprus BioSciences
Deal Brief, Medical Device

Teleflex acquires Semprus BioSciences

Teleflex, Inc. acquired Semprus BioSciences, a Massachusetts-based biocoatings firm. Semprus offers anti-thrombosis coatings for medical devices.

The deal is valued at $30 million with an opportunity for an additional $50 million in earnouts, per CNNMoney.

  • May 11 / 2012
  • Comments Off on LifeNet Health to acquire Northwest Tissue Services
Deal Brief, Life Sciences

LifeNet Health to acquire Northwest Tissue Services

LifeNet Health of Virginia Beach, VA announced its intention to acquire the not-for-profit Northwest Tissue Services of Seattle. LifeNet offers tissue banking and organ donation services.

LifeNet plans a multi-million dollar investment in Northwest to expand its capabilities in servicing the West Coast markets.

  • Apr 04 / 2012
  • Comments Off on MedPlast acquires UPG
Deal Brief, Medical Device

MedPlast acquires UPG

MedPlast Inc. has acquired United Plastics Group. The combined entity will have sales of over $250 million. Approximately 60-70% of the company’s revenues will derive from the medical device market, per Plastics News.

  • Apr 02 / 2012
  • Comments Off on MRPC acquires ETI
Deal Brief, Medical Device

MRPC acquires ETI

MRPC acquired ETI, a liquid silicone molding firm based in Florida. The acquisition brings MRPC a southern hub and 25 employees.

Wisconsin-based MRPC revenues in 2011 were reported as “slightly less than $20 million”.

  • Feb 21 / 2012
  • Comments Off on Theragenics acquires Core Oncology’s prostate brachytherapy customer base
Deal Brief, Medical Device

Theragenics acquires Core Oncology’s prostate brachytherapy customer base

Theragenics (NYSE:TGX) announced its acquisition of Core Oncology’s prostate brachytherapy customer base. Terms of the deal are an earnout equal to one time the revenue generated from the acquired customers over a one year period beginning September 2012 and ending August 2013 in excess of a $2.5 million threshold.

Theragenics paid $3.8 million in cash as prepayment of a portion of the earn-out.

  • Feb 21 / 2012
  • Comments Off on Theragenics acquires Core Oncology’s prostate brachytherapy customer base
Deal Brief, Medical Device

Theragenics acquires Core Oncology’s prostate brachytherapy customer base

Theragenics (NYSE:TGX) announced its acquisition of Core Oncology’s prostate brachytherapy customer base. Terms of the deal are an earnout equal to one time the revenue generated from the acquired customers over a one year period beginning September 2012 and ending August 2013 in excess of a $2.5 million threshold.

Theragenics paid $3.8 million in cash as prepayment of a portion of the earn-out.

  • Jan 31 / 2012
  • Comments Off on AngioDynamics to acquire Navilyst Medical
Deal Brief, Medical Device

AngioDynamics to acquire Navilyst Medical

AngioDynamics (NASDAQ:ANGO) announced on January 31 its intention to acquire competitor Navilyst Medical for $372 million in cash and stock. Navilyst Medical owners Avista Capital Partners acquired the company from Boston Scientific in 2008. Navilyst’s revenues in 2011 were approximately $149 million. Both AngioDynamics and Navilyst Medical service the peripheral vascular market.

AngioDynamics expects combined revenues of $360 million in FY2013 with $60 million EBITDA.

  • Jan 31 / 2012
  • Comments Off on AngioDynamics to acquire Navilyst Medical
Deal Brief, Medical Device

AngioDynamics to acquire Navilyst Medical

AngioDynamics (NASDAQ:ANGO) announced on January 31 its intention to acquire competitor Navilyst Medical for $372 million in cash and stock. Navilyst Medical owners Avista Capital Partners acquired the company from Boston Scientific in 2008. Navilyst’s revenues in 2011 were approximately $149 million. Both AngioDynamics and Navilyst Medical service the peripheral vascular market.

AngioDynamics expects combined revenues of $360 million in FY2013 with $60 million EBITDA.

  • Jan 10 / 2012
  • Comments Off on Remmele sold to RTI International Metals
Deal Brief, Metals

Remmele sold to RTI International Metals

Remmele Engineering, a Minnesota-based precision machining company focused on the medical and aerospace industries, announced its sale to RTI International Metals, Inc. of Pittsburg. The transaction value is set at $182.5 million, $164.5 million to be paid in cash with the remainder being an assumption of debt.

  • Dec 29 / 2011
  • Comments Off on Symmetry Medical closes acquisition of Codman & Shurtleff’s surgical instruments business
Deal Brief, Medical Device

Symmetry Medical closes acquisition of Codman & Shurtleff’s surgical instruments business

Symmetry Medical (NYSE:SMA) announced on December 29th that it had acquired the surgical instruments business from Codman and Shurtleff, a Johnson & Johnson company. The transaction was done for $165.7 million in cash. The Codman & Shurtleff product line will be incorporated into Symmetry’s hospital-direct business unit.

Pages:12345
Inquiries are welcome Contact us